Following Complete Clearance Of Cancer Lesions In Advanced Liver Cancer Patient, Can-Fite Is Filing…
Namodenoson Headed into Pivotal Phase III Liver Cancer Study
Can-Fite BioPharma Ltd, a biotechnology company advancing a pipeline of proprietary…